Polivka, L.; Valyi-Nagy, I.; Szekanecz, Z.; Bogos, K.; Vago, H.; Kamondi, A.; Fekete, F.; Szlavik, J.; Surjan, G.; Surjan, O.;
et al. Waning of SARS-CoV-2 Vaccine Effectiveness in COPD Patients: Lessons from the Delta Variant. Vaccines 2023, 11, 1786.
https://doi.org/10.3390/vaccines11121786
AMA Style
Polivka L, Valyi-Nagy I, Szekanecz Z, Bogos K, Vago H, Kamondi A, Fekete F, Szlavik J, Surjan G, Surjan O,
et al. Waning of SARS-CoV-2 Vaccine Effectiveness in COPD Patients: Lessons from the Delta Variant. Vaccines. 2023; 11(12):1786.
https://doi.org/10.3390/vaccines11121786
Chicago/Turabian Style
Polivka, Lörinc, Istvan Valyi-Nagy, Zoltan Szekanecz, Krisztina Bogos, Hajnalka Vago, Anita Kamondi, Ferenc Fekete, Janos Szlavik, György Surjan, Orsolya Surjan,
and et al. 2023. "Waning of SARS-CoV-2 Vaccine Effectiveness in COPD Patients: Lessons from the Delta Variant" Vaccines 11, no. 12: 1786.
https://doi.org/10.3390/vaccines11121786
APA Style
Polivka, L., Valyi-Nagy, I., Szekanecz, Z., Bogos, K., Vago, H., Kamondi, A., Fekete, F., Szlavik, J., Surjan, G., Surjan, O., Nagy, P., Schaff, Z., Kiss, Z., Müller, C., Kasler, M., & Müller, V.
(2023). Waning of SARS-CoV-2 Vaccine Effectiveness in COPD Patients: Lessons from the Delta Variant. Vaccines, 11(12), 1786.
https://doi.org/10.3390/vaccines11121786
